NCT06456788

Brief Summary

Measles is a highly contagious disease which can result in severe complications in some patients. Healthcare workers have a higher risk of getting measles than the general population because of their increased risk of exposure from patients with measles attending hospitals. Having had measles in the past or at least one dose of the measles, mumps and rubella (MMR) vaccine provides protection (immunity) against measles. UK government guidelines therefore recommend that healthcare workers and non-clinical staff with direct patient contact are fully vaccinated or have other evidence of immunity. Yet, evidence from recent measles outbreaks suggests that some healthcare workers are not immune or do not know if they are immune, with implications for containment efforts, cost and transmission. The purpose of this study is to identify barriers and facilitators to uptake of the MMR vaccine among healthcare workers at King's College Hospital NHS Foundation Trust (KCH). KCH healthcare workers will be eligible to take part in the study if they are aged 18 and over and have direct contact with patients. In addition, the research will focus on four subgroups of healthcare workers at KCH: those who are not immune, those who have not completed the full vaccination schedule, those who don't know their immunity status, those received the vaccine only after joining KCH. The latter may provide insights into facilitators to vaccine uptake. Measles immunity forms part of the occupational health screening at KCH. A series of semi structured interviews lasting approximately 1 hour will explore participants' experiences of the occupational health vaccine screening process and measles vaccine campaigns at KCH; why they are unvaccinated/not fully vaccinated/do not know if they are immune/decided to be vaccinated after joining KCH; and what measures or interventions may help healthcare workers when deciding whether to get the MMR vaccine.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
23

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Sep 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 30, 2024

Completed
14 days until next milestone

First Posted

Study publicly available on registry

June 13, 2024

Completed
3 months until next milestone

Study Start

First participant enrolled

September 12, 2024

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 19, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 19, 2024

Completed
Last Updated

May 6, 2025

Status Verified

April 1, 2025

Enrollment Period

3 months

First QC Date

May 30, 2024

Last Update Submit

May 1, 2025

Conditions

Outcome Measures

Primary Outcomes (3)

  • Barriers to MMR vaccination

    Barriers to MMR vaccination will be explored in the qualitative interview

    Collected at one timepoint 1 day during qualitative interview

  • Facilitators to MMR vaccination

    Facilitators to MMR vaccination will be explored in the qualitative interview

    Collected at one timepoint 1 day during qualitative interview

  • Reasons for not knowing immunity status

    Reasons for not knowing immunity status will be explored in the qualitative interview

    Collected at one timepoint 1 day during qualitative interview

Secondary Outcomes (1)

  • Experiences of the occupational health vaccine screening process at KCH

    Collected at one timepoint 1 day during qualitative interview

Study Arms (1)

Healthcare workers

Healthcare workers at one Trust who have direct patient contact and fall within one of four groups: 1) they are not immune to measles (have not had measles in the past and have not been vaccinated with both doses of the MMR vaccine), 2) they have not completed the full vaccination schedule (they have received only 1 dose of the MMR vaccine), 3) they do not know their immunity status, and 4) they received the MMR vaccine after joining the Trust.

Biological: MMR vaccination

Interventions

MMR vaccinationBIOLOGICAL

MMR vaccination status

Healthcare workers

Eligibility Criteria

Age18 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Participants will be recruited from a population of hospital-based healthcare workers, including doctors, nurses, health assistants, etc. Healthcare workers will be recruited from one site only (KCH).

You may qualify if:

  • Are aged 18 and over
  • Currently work as a healthcare worker at the Trust
  • Have direct contact with patients
  • Don't know if they have had measles and don't know if they have been vaccinated
  • Or: Have not had measles and have not received the MMR vaccine
  • Or: Have only received 1 dose of the MMR vaccine
  • Or: Received the MMR vaccine after joining the Trust

You may not qualify if:

  • Are aged \<18 years old
  • Work in a role at the Trust that does not involve direct contact with patients (e.g., administrative or business staff)
  • Are sure and/or have evidence that they have had measles in the past or both doses of the MMR vaccine before joining the Trust
  • Are not able to give informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

King's College London

London, London, United Kingdom

Location

MeSH Terms

Conditions

Measles

Condition Hierarchy (Ancestors)

Morbillivirus InfectionsParamyxoviridae InfectionsMononegavirales InfectionsRNA Virus InfectionsVirus DiseasesInfections

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 30, 2024

First Posted

June 13, 2024

Study Start

September 12, 2024

Primary Completion

December 19, 2024

Study Completion

December 19, 2024

Last Updated

May 6, 2025

Record last verified: 2025-04

Locations